MODE Diagnostics has secured more than £1.1 million of new funding.

The Glasgow University spin-out raised £975,000 from investors along with a further £136,000 from business and research and development grants.

The money is being put towards developing the health screening products that include a home test for bowel health.

That product, called bSURE, is said to be well advanced with the latest cash helping push it closer to a commercial launch.

IP Group and the Scottish Investment Bank were return investors while London based Parkwalk Advisors plus Glasgow University Holdings and Kelvin Capital put money in for the first time.

The existing directors and management of MODE have also invested.

Chief executive Dr Paul Heaney said: "MODE is all about giving health-conscious consumers products that will let them screen their health and benefit from the improved outcomes of treating diseases at an early stage.

"Our products give early warnings and this can lead to highly successful early medical treatments."

Dr Brian Horsburgh, from IP Group, said: "MODE's clear route to market, commercially attractive products and proven management provide a compelling opportunity."